High Purity 2023788-19-2 tirzepatide Loss Weight 10mg 20mg 30mg Vials Peptide
2099 Inquiries
2023788-19-2
Pharmaceutical Grade
99%
shenzhen
CQ
5mg*10vials,10vials/box
Yes
2025-12-26
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,copper peptide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,copper peptide
-
Location:
room 102, No. 60-20, Gongnong Street, Xiangya Road Subdistrict, Kaifu District, Changsha City, Hunan Province, China
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment
-
Average lead Time:
2 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
-
Inquiry History2099 Inquiries
Country Product Purchase Quantity Date Posted
Philippines
Tirzepatide
2 MT Oct 27, 2026
Philippines
Tirzepatide
30 MG Oct 26, 2026
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026
United States
Tirzepatide
50 MG Oct 20, 2026
Spain
tirzepatide
20 MG Oct 19, 2026
United States
tirzepatide
30 MG Oct 19, 2026
Philippines
tirzepatide
40 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
Tirzepatide
20 MG Oct 19, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Peptide Dsip Epitalon Ghk-Cu Humanin Ll-37 P21 Thymosin Alpha 1 Selank Semax Oxytocin Thymalin
Pharmaceutical Grade / 99%
-
-
-
-
99% Purity Peptides Epithalon CAS 307297-39-8 Retatrutide Tirzepatide Cagrilintide Kpv Thymosin Alpha-1
Pharmaceutical Grade / 99%
-
-
-
-
GHK Cu Copper Peptide Factory Supply Delivery within One Day Us Warehouse Supply CAS 49557-75-7
Pharmaceutical Grade / 99%
-
-
-
-
NAD best feedback Retatrutide 10mg 15mg vials 99 purity peptide lyophilized powder sale
Pharmaceutical Grade / 99%
-